Regeneron Pharmaceuticals (REGN) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free REGN Stock Alerts $890.68 -15.86 (-1.75%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Regeneron Pharmaceuticals Stock Price Performance5 Day Performance-0.68%1 Month Performance-7.56%3 Month Performance-5.25%6 Month Performance+12.46%Year-To-Date Performance+1.41%1 Year Performance+14.48% Receive REGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). REGN Stock Chart for Friday, April, 26, 2024 REGN Chart by TradingView Regeneron Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$906.54$890.68-1.75%$915.00$876.75574,971 shs$97.76 billion04/24/2024$907.32$906.54-0.09%$915.70$904.41369,734 shs$99.50 billion04/23/2024$900.16$907.32+0.80%$912.74$903.83336,829 shs$99.59 billion04/22/2024$896.82$900.16+0.37%$908.50$897.68351,366 shs$98.80 billion04/19/2024$893.99$896.82+0.32%$920.73$891.46507,464 shs$98.43 billion04/18/2024$901.19$893.99-0.80%$908.81$892.15450,591 shs$98.12 billion Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$894.14$901.19+0.79%$911.64$899.90468,666 shs$98.91 billion04/16/2024$898.56$894.14-0.49%$901.07$890.43615,755 shs$98.14 billion04/15/2024$904.70$898.56-0.68%$921.12$895.09656,348 shs$98.63 billion04/12/2024$920.32$904.70-1.70%$912.22$898.26665,264 shs$99.30 billion04/11/2024$936.20$920.32-1.70%$930.64$907.33617,049 shs$101.01 billion04/10/2024$943.89$936.20-0.81%$937.87$923.44389,657 shs$102.76 billion04/09/2024$938.48$943.89+0.58%$949.20$938.34305,891 shs$103.60 billion04/08/2024$942.70$938.48-0.45%$942.99$935.51330,916 shs$103.01 billion04/05/2024$937.02$942.70+0.61%$949.83$934.87363,541 shs$103.47 billion04/04/2024$950.95$937.02-1.46%$962.20$935.36396,071 shs$102.85 billion04/03/2024$954.68$950.95-0.39%$961.68$950.43413,236 shs$104.38 billion04/02/2024$969.31$954.68-1.51%$961.44$951.02434,469 shs$104.79 billion04/01/2024$962.49$969.31+0.71%$970.20$954.09347,953 shs$106.39 billion03/29/2024$962.49$962.49$970.79$959.25461,867 shs$105.64 billion03/28/2024$966.30$962.49-0.39%$970.79$959.25461,802 shs$105.64 billion03/27/2024$963.55$966.30+0.29%$976.75$962.41314,751 shs$106.06 billion03/26/2024$961.09$963.55+0.26%$966.68$957.78386,832 shs$105.76 billion03/25/2024$967.24$961.09-0.64%$964.98$952.47315,187 shs$105.49 billion03/22/2024$968.01$967.24-0.08%$977.39$966.47274,403 shs$106.16 billion03/21/2024$966.96$968.01+0.11%$979.26$968.00435,118 shs$106.25 billion03/20/2024$963.66$966.96+0.34%$967.20$947.37577,042 shs$106.13 billion03/19/2024$959.92$963.66+0.39%$969.16$959.14365,327 shs$105.77 billion03/18/2024$964.47$959.92-0.47%$970.71$959.49360,151 shs$105.36 billion03/15/2024$959.04$964.47+0.57%$968.51$953.721.08 million shs$105.86 billion03/14/2024$965.47$959.04-0.67%$969.18$950.97507,294 shs$105.26 billion03/13/2024$970.57$965.47-0.53%$979.82$963.83381,553 shs$105.97 billion03/12/2024$964.44$970.57+0.64%$975.93$963.00358,510 shs$106.53 billion03/11/2024$968.83$964.44-0.45%$979.80$960.44355,624 shs$105.86 billion03/08/2024$973.31$968.83-0.46%$976.00$962.82343,274 shs$106.34 billion03/07/2024$972.10$973.31+0.12%$979.25$969.96380,461 shs$106.83 billion03/06/2024$965.21$972.10+0.71%$974.17$955.56366,436 shs$106.70 billion03/05/2024$971.19$965.21-0.62%$977.67$953.29394,384 shs$105.94 billion03/04/2024$982.82$971.19-1.18%$985.21$966.22420,115 shs$106.60 billion03/01/2024$966.09$982.82+1.73%$988.13$966.09368,576 shs$107.88 billion“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).02/29/2024$987.61$966.09-2.18%$990.30$965.16792,164 shs$106.04 billion02/28/2024$993.35$987.61-0.58%$998.32$987.61485,921 shs$108.40 billion02/27/2024$989.28$993.35+0.41%$995.41$975.22461,518 shs$109.03 billion02/26/2024$981.20$989.28+0.82%$995.97$975.00541,218 shs$108.58 billion02/23/2024$964.89$981.20+1.69%$985.64$969.15439,607 shs$107.70 billion02/22/2024$952.84$964.89+1.26%$973.00$947.85614,731 shs$105.91 billion02/21/2024$946.87$952.84+0.63%$958.00$945.70293,677 shs$104.58 billion02/20/2024$948.05$946.87-0.12%$963.00$943.73417,733 shs$103.93 billion02/19/2024$948.05$948.05$956.52$944.12367,400 shs$104.06 billion02/16/2024$954.73$948.05-0.70%$956.52$944.12366,328 shs$103.29 billion02/15/2024$947.82$954.73+0.73%$958.74$949.09334,346 shs$104.01 billion02/14/2024$940.48$947.82+0.78%$951.83$936.70373,517 shs$103.26 billion02/13/2024$947.06$940.48-0.69%$947.46$933.80456,910 shs$102.47 billion02/12/2024$953.42$947.06-0.67%$954.53$941.01603,834 shs$103.18 billion02/09/2024$946.43$953.42+0.74%$957.51$945.85613,775 shs$103.88 billion02/08/2024$938.49$946.43+0.85%$947.24$930.04487,586 shs$103.11 billion02/07/2024$937.81$938.49+0.07%$954.30$933.46456,359 shs$102.25 billion02/06/2024$936.33$937.81+0.16%$945.46$927.52460,417 shs$102.17 billion02/05/2024$945.18$936.33-0.94%$939.50$923.03694,611 shs$102.01 billion02/02/2024$957.78$945.18-1.32%$973.99$939.31751,937 shs$102.98 billion02/01/2024$942.78$957.78+1.59%$964.93$937.47519,742 shs$104.35 billion01/31/2024$959.73$942.78-1.77%$965.66$941.19601,534 shs$102.72 billion01/30/2024$955.80$959.73+0.41%$960.21$945.10366,136 shs$104.56 billion01/29/2024$940.05$955.80+1.68%$957.67$943.99529,960 shs$104.13 billion01/26/2024$948.87$940.05-0.93%$958.15$939.06460,157 shs$102.42 billion01/25/2024$948.24$948.87+0.07%$957.75$945.40394,113 shs$103.38 billion Related Companies: Vertex Pharmaceuticals Stock Price Chart Bristol-Myers Squibb Stock Price Chart Sanofi Stock Price Chart GSK Stock Price Chart Zoetis Stock Price Chart Takeda Pharmaceutical Stock Price Chart Royalty Pharma Stock Price Chart Abbott Laboratories Stock Price Chart BeiGene Stock Price Chart Catalent Stock Price Chart Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REGN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.